Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint

Arthritis and Rheumatism

Volumn 44, Issue 1, 2001, Pages 31-40

  Koch, Alisa E ^a   Volin, Michael V ^a   Woods, James M ^a   Kunkel, Steven L ^b   Connors, Matthew A ^a   Harlow, Lisa A ^a   Woodruff, Drew C ^a   Burdick, Marie D ^c   Strieter, Robert M ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTAXIS; CORNEA NEOVASCULARIZATION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; NONHUMAN; PANNUS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE HOMOGENATE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; ARTHROPLASTY; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHIL ACTIVATION; SYNOVIAL MEMBRANE;

EID: 0035147088     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4     Document Type: Article

References (75)

1. Pathogenesis of rheumatoid arthritis: A disorder associated with dysfunctional immunoregulation
2. Rheumatoid arthritis: Pathophysiology and implications for therapy
3. Rheumatoid arthritis
4. Angiogenesis in rheumatoid arthritis: Pathogenic and clinical significance
5. Angiogenesis: Implications for rheumatoid arthritis
6. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
7. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
8. Hepatocyte growth factor: A cytokine mediating endothelial migration in inflammatory arthritis
9. Interleukin-8 as a macrophage-derived mediator of angiogenesis
10. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): Specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid
11. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis
12. Adhesion molecules in rheumatoid arthritis
13. Cytokine blockade as a new strategy to treat rheumatoid arthritis: Inhibition of tumor necrosis factor
14. The role of cytokines in the pathogenesis of rheumatoid arthritis
15. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells
16. Production of platelet derived growth factor B chain (PDGF-B/c-sis) mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: Coexpression with heparin binding acidic fibroblast growth factor-1
17. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis
18. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis
19. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF)
20. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding
21. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg
22. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
23. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8
24. Epithelial neutrophil activating peptide-78: A novel chemotactic cytokine for neutrophils in arthritis
25. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
26. Growth-related gene product alpha: A chemotactic cytokine for neutrophils in rheumatoid arthritis
27. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
28. The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis
29. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages
30. Monoclonal antibodies defining shared human macrophage-endothelial antigens
31. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
32. Macrophage inflammatory protein-1 alpha: A novel chemotactic cytokine for macrophages in rheumatoid arthritis
33. Cytokine profiles of cultured microvascular endothelial cells from the human intestine
34. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids
35. Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis
36. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
37. Angiogenesis: A critical process in the pathogenesis of RA - A role for VEGF?
38. Increased synovial expression of TGF-β receptor endoglin and TGF-β1 in rheumatoid arthritis
39. Active and latent forms of transforming growth factor β activity in synovial effusions
40. Intra-articular injection of transforming growth factor β1 (TGF/β1) in rat knee joints mimics events associated with early stages of arthritis
41. Transforming growth factor β1 (TGF-β1) induced neutrophil recruitment to synovial tissues: Implications for TGF-β-driven synovial inflammation and hyperplasia
42. Transforming growth factor-β in rheumatoid arthritis
43. Transforming growth factor-β1 in rheumatoid synovial membrane and cartilage/pannus junction
44. Expression of basic fibroblast growth factor and angiogenin in arthritis
45. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease
46. Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis
47. Expression of basic fibroblast growth factor in synovial tissues from patients with rheumatoid arthritis: Detection by immunohistological staining and in situ hybridisation
48. Chemokine receptors in human endothelial cells: Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines
49. IL-8 specifically binds to endothelial but not to smooth muscle cells
50. Signals and receptors involved in recruitment of inflammatory cells
51. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelialcell-derived neutrophil attractant-78
52. Collagenase inhibition by cationic proteins derived from cartilage and aorta
53. Inhibition of tumor angiogenesis mediated by cartilage
54. Isolation of a cartilage factor that inhibits tumor neovascularization
55. Inhibition of neovascularization by a cartilage factor
56. Shark cartilage contains inhibitors of tumor angiogenesis
57. Control of tumor growth in animals by infusion of an angiogenesis inhibitor
58. A cartilage-derived inhibitor of neovascularization and metalloproteinases
59. Cytokines in autoimmune diseases
60. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
61. Inhibition of angiogenesis by interleukin 4
62. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
63. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
64. TNF-α in rheumatoid arthritis and prospects of anti-TNF therapy
65. Targeting TNF alpha for the therapy of rheumatoid arthritis
66. TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
67. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
68. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
69. New directions for biological therapy in rheumatoid arthritis
70. TNF alpha is an effective therapeutic target for rheumatoid arthritis
71. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis
72. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
73. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
74. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist
75. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor a antibody in rheumatoid arthritis